Interventional Study in Individuals with Multiple Sclerosis
An interventional study was planned with 15 participants diagnosed with Multiple Sclerosis or Fibromyalgia, to compare active full-body stimulation against sham stimulation. The primary endpoint was the Berg Balance Scale. No results have been posted yet.
- Tags
- #MSResearch
- Most relevant to
- —
- Source
- Read original source
- Human efficacy
- Not established from this source
- Mechanism
- Not reported
- Evidence strength
- No results yet
- Outcome
- Not reported
Why it matters
This research aims to evaluate the effects of stimulation on balance in individuals with MS, potentially informing future therapies. However, the lack of results means we can't determine if this intervention was effective.
What this does not prove
The study is still ongoing with no findings reported and endpoints not established. Therefore, its implications remain unknown.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Interventional
- Participants / samples
- 15 · planned enrolment
- Randomised
- Yes
- Controlled
- Yes
- Primary endpoint met
- Not reported
- Relevant MS type
- All
- Publication date
- Not reported
- Evidence reviewed
- Trial registry record
- Regulatory approval
- Not reported
- Research areas
- Not classified
- Biological target
- Not reported
- Pathway
- Not reported
- Population
- Individuals with a diagnosis of Multiple Sclerosis or Fibromyalgia; ages from 18 Years to 75 Years
- Size of effect
- Not reported
- Secondary endpoints
- Not reported
- MRI endpoints
- Not reported
- Biomarkers
- Not reported
- Safety
- Not reported
Original sources
Supporting passages (15)
study phasePhase: Not applicable
study designStudy type: Interventional
subjectsParticipants: people; ages from 18 Years to 75 Years; sex All
sample sizeEnrollment: 15 participants (estimated)
randomizedAllocation: Randomized
controlledArm types: Experimental; Sham comparator
relevant ms typesConditions: Multiple Sclerosis; Fibromyalgia; Neurologic Disorder; Neuromuscular Disorders
primary endpointPrimary endpoints: Berg Balance Scale
populationhaving a definite diagnosis for at least one month\n 2.
findingsTrial registry record. Publication date: unknown. No results are posted. Planned enrolment and endpoints are not findings.
limitationsTrial registry record. Publication date: unknown. No results are posted. Planned enrolment and endpoints are not findings.
peer reviewedTrial registry record.
interventionInterventions: Active full-body stimulation; Sham full-body stimulation
follow upFollow-up: Baseline 1 (prior to Arm 1)- initial visit, Endpoint 1 (after Arm 1)- at ~2 weeks, Baseline 2 (after 2 week washout and before Arm 2)- at ~4 weeks, Endpoint 2 (after Arm 2)- at ~6 weeks, Follow-Up (2 weeks after Endpoint 2)- at ~8 weeks
sample size basisEnrollment: 15 participants (estimated)
AI assessment, not yet reviewed by a person · version 3 · Community votes are separate from evidence review.